Day: March 19, 2020

Worksport U.S. Patent Office trademark finally registered, a last step granting 10-year rights to the Worksport identity TerraVis name for mobile panel and solar generator system applied for and published in China, Europe, Canada, U.S.TORONTO, March 19, 2020 (GLOBE NEWSWIRE) — Franchise Holdings International Inc., (OTCQB: FNHI) (or the “Company”) Worksport Ltd.’s parent company, is marking yet another milestone in its plan to strongly secure its intellectual property as the U.S. Patent Office on March 17 notified the Company that its Worksport trademark has been finally registered. This notice, a last step, grants exclusive 10-year U.S. rights to the name. In addition, protection for TerraVis, Worksport’s unique mobile panel and solar generator system for light trucks, has now been applied for and published in China, Europe, Canada,...

Successfully Finished 2019 with Initiation of Two Pivotal Phase 3 Trials for Vonoprazan in Erosive Esophagitis (PHALCON-EE) and H. pylori Infection (PHALCON-HP) and Completion of $209M Initial Public OfferingTemporarily Pausing New Patient Randomization in PHALCON-EE and PHALCON-HP Trials in View of COVID-19 PandemicMark Stenhouse, General Manager – Screening Business, Exact Sciences, Appointed to Board of DirectorsFLORHAM PARK, N.J., March 19, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided an update on the status of its Phase 3 PHALCON-EE and PHALCON-HP clinical trials...

Fourth Quarter Net Sales Increase 21% Sequentially and 13% Year-over-Year to $3.5 MillionConference Call to be Held Today at 11AM ETSOLON, Ohio, March 19, 2020 (GLOBE NEWSWIRE) — Energy Focus, Inc. (NASDAQ:EFOI), a leader in sustainable LED lighting technologies, today announced financial results for its fourth quarter and fiscal year ended December 31, 2019.Fourth Quarter 2019 and Subsequent Business HighlightsNet sales of $3.5 million, up 21.1% from third quarter 2019 and up 13.2% from fourth quarter 2018Net loss of $1.3 million, a year-over-year improvement of $1.7 millionAwarded a $2.5 million contract to supply LED globe lights and a $3.4 million contract to supply tubular LED (TLED) lighting products to the U.S. Navy, as well as a $1.7 million contract to supply LED lighting products for four new ship for a U.S. allied NavyFiled...

DALLAS, March 19, 2020 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an owner and operator of entertainment and dining venues, today announced that it has adopted a 364-day duration Shareholder Rights Plan (the “Rights Plan”), effective March 18, 2020.The Rights Plan is similar to plans adopted by other public companies, and is intended to promote the fair and equal treatment of all Dave & Buster’s shareholders and ensure that no person or group can gain control of Dave & Buster’s through open market accumulation or other tactics potentially disadvantaging the interest of all shareholders. The Rights Plan will also position the Dave & Buster’s Board of Directors to fulfill its fiduciary duties on behalf of...

WASHINGTON, DC and ATLANTA, GA, March 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Xalles Holdings Inc. (OTC: XALL), a fintech holding company leveraging blockchain technology for financial reconciliation and payment auditing solutions, today announces that it has executed a Share Purchase Agreement to acquire 100% of MinervaWorks Holdings, Inc., an Atlanta based technology company.Under the Share Purchase Agreement, Xalles Holdings Inc. will acquire all of the common shares of MinervaWorks Holdings, Inc., which in turn will wholly own the two subsidiaries, Minerva Automation, Inc. and MinervaWorks, LLC.  The MinervaWorks main office is located a short distance from Truist Park, the home field of the Atlanta Braves baseball club. MinervaWorks has been providing technology solutions since 1986 when Minerva Automation was...

Suominen Corporation’s Stock Exchange Release on March 19, 2020 at 2:30 p.m. (EET)The AGM adopted the Financial Statements for 2019 and discharged the members of the Board of Directors and the President and CEO from liability for the 2019 financial year. The AGM approved the Remuneration Policy for the governing bodies and the Board of Directors’ proposals concerning the authorization for the Board to decide on repurchasing of the company’s shares as well as issuance of shares and granting of options and other special rights entitling to shares.60% of the annual fee is paid in cash and 40% in Suominen Corporation’s shares. The number of shares to be transferred will be determined based on the share value in the stock exchange trading maintained by Nasdaq Helsinki Ltd, calculated as the trade volume weighted average quotation...

AUSTIN, Texas, March 19, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced clinical updates and business progress across its pipeline of product candidates under development.“Our clinical programs show no signs of slowing down,” said Remi Barbier, President & CEO. “Alzheimer’s continues to be a devastating disease in need of solutions, and I believe impressive scientific progress across the industry will accelerate into 2020 and beyond. Now more than ever, we feel it’s important to communicate our values and progress. With this backdrop, we are pleased to report that our business is firing on all cylinders.”Business UpdateCassava Sciences is building a leading position in Alzheimer’s R&D by focusing on the development of...

SAN DIEGO, March 19, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today the appointment of Saundra Pelletier, Chief Executive Officer, President and Executive Director of Evofem Biosciences, Inc., to its Board of Directors. “We are very pleased to welcome Saundra to the TRACON Board,” said Dr. Charles Theuer, President and Chief Executive Officer of TRACON. “Her strong track record of successful strategic, operational and financial management, combined with her vast commercial experience will be invaluable to TRACON as we execute on...

SHANGHAI, China, March 19, 2020 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS), a leading developer and operator of high-performance data centers in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2019.Fourth Quarter 2019 Financial HighlightsNet revenue increased by 42.2% year-over-year (“Y-o-Y”) to RMB1,179.2 million (US$169.4 million) in the fourth quarter of 2019 (4Q2018: RMB829.5 million).Service revenue increased by 39.9% Y-o-Y to RMB1,159.6 million (US$166.6 million) in the fourth quarter of 2019 (4Q2018: RMB829.1 million).Net loss was RMB103.7 million (US$14.9 million) in the fourth quarter of 2019, compared with a net loss of RMB122.9 million in the fourth quarter of 2018.Adjusted EBITDA (non-GAAP) increased by 59.3%...

See attachment. Attachment20200319 – Flöggun Skeljungur eigin hlutir